OBJECTIVE: To evaluate the function of human ovarian transplants. DESIGN: Follow a series of fresh ovarian transplants for up to 5 years, and compare fresh and frozen ovarian tissue transplantation. SETTING: Tertiary referral community hospital. PATIENT(S): Nine women with premature ovarian failure who received an ovary donated from a monozygotic twin sibling, and 16 young cancer patients undergoing ovarian cryopreservation. Two of the transplant recipients were cancer survivors rendered sterile by their therapy. INTERVENTION(S): Fresh ovary transplantation between monozygotic twin sisters, as well as transplantation of previously frozen ovarian tissue, and study of cryopreserved tissue in cancer patients. MAIN OUTCOME MEASURE(S): Return of normal menstrual cycling, hormone levels, pregnancy, healthy babies, duration of transplant function, and ovarian tissue evaluation. RESULT(S): Normal serum FSH and regular menstrual cycles returned by 5 months after surgery in all cases, both fresh and frozen. Fourteen spontaneous pregnancies were established leading to eight healthy live births and two healthy ongoing conceptions. All three frozen tissue transplants conceived spontaneously, one delivered, and two were ongoing. Oocyte survival with slow freezing was 42% and after vitrification 89%. CONCLUSION(S): Ovarian transplantation in humans is a robust procedure, even after cryopreservation, and vitrification might prove to be more effective than slow freezing.
OBJECTIVE: To evaluate the function of human ovarian transplants. DESIGN: Follow a series of fresh ovarian transplants for up to 5 years, and compare fresh and frozen ovarian tissue transplantation. SETTING: Tertiary referral community hospital. PATIENT(S): Nine women with premature ovarian failure who received an ovary donated from a monozygotic twin sibling, and 16 young cancerpatients undergoing ovarian cryopreservation. Two of the transplant recipients were cancer survivors rendered sterile by their therapy. INTERVENTION(S): Fresh ovary transplantation between monozygotic twin sisters, as well as transplantation of previously frozen ovarian tissue, and study of cryopreserved tissue in cancerpatients. MAIN OUTCOME MEASURE(S): Return of normal menstrual cycling, hormone levels, pregnancy, healthy babies, duration of transplant function, and ovarian tissue evaluation. RESULT(S): Normal serum FSH and regular menstrual cycles returned by 5 months after surgery in all cases, both fresh and frozen. Fourteen spontaneous pregnancies were established leading to eight healthy live births and two healthy ongoing conceptions. All three frozen tissue transplants conceived spontaneously, one delivered, and two were ongoing. Oocyte survival with slow freezing was 42% and after vitrification 89%. CONCLUSION(S): Ovarian transplantation in humans is a robust procedure, even after cryopreservation, and vitrification might prove to be more effective than slow freezing.
Authors: Christopher C Dvorak; Clarisa R Gracia; Jean E Sanders; Edward Y Cheng; K Scott Baker; Michael A Pulsipher; Anna Petryk Journal: Biol Blood Marrow Transplant Date: 2011-10-17 Impact factor: 5.742
Authors: Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Candace Tingen; Cristina Thomas; Jessina Thomas; M Patrick Lowe; Julian C Schink; Teresa K Woodruff Journal: Reprod Sci Date: 2013-10-04 Impact factor: 3.060
Authors: Brigitte Gerstl; Elizabeth Sullivan; Jana Koch; Handan Wand; Angela Ives; Richard Mitchell; Nada Hamad; Antoinette Anazodo Journal: Support Care Cancer Date: 2019-09-21 Impact factor: 3.603
Authors: Kate E Waimey; Francesca E Duncan; H Irene Su; Kristin Smith; Harlan Wallach; Kemi Jona; Christos Coutifaris; Clarisa R Gracia; Lonnie D Shea; Robert E Brannigan; R Jeffrey Chang; Mary B Zelinski; Richard L Stouffer; Robert L Taylor; Teresa K Woodruff Journal: J Adolesc Young Adult Oncol Date: 2013-03 Impact factor: 2.223